Skip to main content
. 2018 Aug 3;97(31):e11677. doi: 10.1097/MD.0000000000011677

Figure 2.

Figure 2

ASAS40 responses to etanercept among different genotypes of rs767455, rs223464 and rs1061622 (%). Only rs1061622 was significantly associated with long-term efficacy of etanercept. A higher frequency of ASAS40 response at 12 months was observed in the patients with TT/GG genotype compared with the patients with TG genotype (66.7% vs 35.3%, P = .021).